Phase II trial for the benefit of leucine containing jelly on exercise fatigue

Phase II trial for the benefit of leucine containing jelly on exercise fatigue - Trial for the benefit of leucine on exercise fatigue

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000038102

Enrollment

Registered

2019-09-26

Start date

2019-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy subjects

Interventions

non leucine jelly 0g leucine containg jelly 2g leucine containg jelly 4g

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: healthy subjects people who have exercise habit 4 days per week men and women over 20 years old

Exclusion criteria

Exclusion criteria: people who have been diagnosis of metabolic syndrome, disease of brain, heart, liver, kidney etc hypertension glucose intorerance

Design outcomes

Primary

Measure	Time frame
improvement of fatigue	—

Countries

Japan

Contacts

Public ContactRie Tsutsumi

Tokushima University Nutrition and Metabolism

rtsutsumi@tokushima-u.ac.jp088-633-7090

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026